Lv2
140 积分 2022-05-10 加入
From concept to clinic: Cutting-Edge advances steering the next wave of antibody–drug conjugates innovation
11天前
已完结
DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
21天前
已完结
Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases
21天前
已完结
Trastuzumab Deruxtecan plus Pertuzumab for HER2-Positive Metastatic Breast Cancer
21天前
已完结
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
21天前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
21天前
已完结
Trastuzumab Deruxtecan for ERBB2 -Mutant Metastatic Non–Small Cell Lung Cancer With or Without Brain Metastases
22天前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
24天前
已完结
Novel antibody drug conjugates containing exatecan derivative-based cytotoxic payloads
1个月前
已完结
Human Epidermal Growth Factor Receptor 2-Mutant Non-Small-Cell Lung Cancer: Continued Progress But Challenges Remain
1个月前
已完结
皖公网安备34019202002308
